Successful immunosuppressive drug-free immune tolerance induction in hemophilia B with inhibitor and anaphylaxis to factor IX: A case report

被引:0
|
作者
Bravo, Angeles Palomo [1 ]
Bonilla, Rosario Prieto [1 ]
Rebollar, Daniel Bardan [1 ]
Lopez-Jaime, Francisco Jose [2 ]
Fernandez-Bello, Ihosvany [2 ]
机构
[1] Hosp Reg Univ Materno Infantil Malaga, Hematol Serv, Malaga, Spain
[2] Hosp Reg Univ Malaga, Hematol Serv, Thrombosis & Hemostasis Unit, Malaga, Spain
来源
CLINICAL CASE REPORTS | 2024年 / 12卷 / 08期
关键词
anaphylaxis reaction; desensitization protocol; factor IX-extended half-life product; immune tolerance induction; inhibitors; severe hemophilia B; DESENSITIZATION; MUTATIONS;
D O I
10.1002/ccr3.9312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recommendations advise factor IX desensitization before immune tolerance induction in severe hemophilia B, supported by immunosuppression. A child with inhibitor and anaphylaxis to factor IX showed successful immunosuppression-free immune tolerance induction using very low and slowly increasing doses of a factor IX extended-half-life product. Immune tolerance to factor IX based on this protocol merits further study.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Case report: Induction of immune tolerance to factor VIII inhibitor after a major operation
    Ho, Liam-Pock
    Ho, Yoke-Kum
    Tien, Sim-Leng
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2007, 36 (06) : 431 - 434
  • [22] Successful second ITI with factor IX and combined immunosuppressive therapy A patient with severe haemophilia B and recurrence of a factor IX inhibitor
    Holstein, K.
    Schneppenheim, R.
    Schrum, J.
    Bokemeyer, C.
    Langer, F.
    HAMOSTASEOLOGIE, 2014, 34 (4A): : S5 - S8
  • [23] Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient
    Verghese, Priya
    Darrow, Stephen
    Kurth, Margaret H.
    Reed, Robyn C.
    Kim, Youngki
    Kearney, Susan
    PEDIATRIC NEPHROLOGY, 2013, 28 (05) : 823 - 826
  • [24] Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient
    Priya Verghese
    Stephen Darrow
    Margaret H. Kurth
    Robyn C. Reed
    Youngki Kim
    Susan Kearney
    Pediatric Nephrology, 2013, 28 : 823 - 826
  • [25] Successful induction of immune tolerance with FIX recombinant in a patient with haemophilia B with inhibitor
    Soto, I
    Vicente, JM
    Corte, JR
    Urgellés, MF
    Pinto, CR
    HAEMOPHILIA, 2004, 10 (04) : 401 - 404
  • [26] Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice
    Verma, Dheeraj
    Moghimi, Babak
    LoDuca, Paul A.
    Singh, Harminder D.
    Hoffman, Brad E.
    Herzog, Roland W.
    Daniell, Henry
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) : 7101 - 7106
  • [27] The results of immune tolerance induction in polish children with severe hemophilia A complicated by factor VIII inhibitor
    Klukowska, A.
    Laguna, P.
    Dobaczewski, G.
    Janik-Moszant, A.
    Kamienska, E.
    Koltan, A.
    Pietrys, D.
    Wlazlowski, M.
    Waleszkiewicz-Majewska, B.
    HAEMOPHILIA, 2012, 18 : 91 - 91
  • [29] Maintenance of immune tolerance in hemophilia B dogs by subcutaneous administration of recombinant human factor IX (benefix™).
    Russell, KE
    Nichols, TC
    Elwell, DR
    Bellinger, DA
    Rup, BJ
    Keith, JC
    Leitermann, K
    McCarthy, KP
    Schaub, RG
    Read, MS
    BLOOD, 1998, 92 (10) : 554A - 555A
  • [30] Successful multi-modal immune tolerance induction for factor IX deficiency with inhibitors and allergic reactions
    Kuhn, J.
    Noda, C.
    Massey, G. V.
    HAEMOPHILIA, 2018, 24 (03) : E133 - E136